Bristol-Myers Squibb Income Statement
View: Annual | Quarterly
| Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
|
|---|---|---|---|---|---|
| Revenue | 4,913.0 | 5,181.0 | 4,894.0 | 5,050.0 | 4,928.0 |
| Cost of Goods Sold | 1,583.0 | 1,657.0 | 1,655.0 | 1,622.0 | 1,549.0 |
| Gross Profit | 3,330.0 | 3,524.0 | 3,239.0 | 3,428.0 | 3,379.0 |
| Gross Profit Margin | 67.8% | 68.0% | 66.2% | 67.9% | 68.6% |
| SG&A Expense | 2,159.0 | 2,108.0 | 2,736.0 | 1,932.0 | 2,183.0 |
| Depreciation & Amortization | 203.0 | 251.0 | 254.0 | 213.0 | 209.0 |
| Operating Income | 968.0 | 1,165.0 | 249.0 | 1,283.0 | 987.0 |
| Operating Margin | 19.7% | 22.5% | 5.1% | 25.4% | 20.0% |
| Nonoperating Income | (53.0) | 34.0 | (132.0) | 98.0 | 149.0 |
| Nonoperating Expenses | (73.0) | 73.0 | (325.0) | 109.0 | 107.0 |
| Income Before Taxes | 1,138.0 | 1,290.0 | 49.0 | 1,411.0 | 1,157.0 |
| Income Taxes | 229.0 | 359.0 | 118.0 | 342.0 | 257.0 |
| Net Income After Taxes | 909.0 | 931.0 | (69.0) | 1,069.0 | 900.0 |
| Continuing Operations | 668.0 | 701.0 | (286.0) | 858.0 | 706.0 |
| Discontinued Operations | 96.0 | (40.0) | 197.0 | -- | -- |
| Total Operations | 764.0 | 661.0 | (89.0) | 858.0 | 706.0 |
| Total Net Income | 764.0 | 661.0 | (89.0) | 858.0 | 706.0 |
| Net Profit Margin | 15.6% | 12.8% | -- | 17.0% | 14.3% |
| Diluted EPS from Total Net Income ($) | 0.39 | 0.33 | (0.05) | 0.43 | 0.36 |
| Dividends per Share | 0.31 | 0.31 | 0.28 | 0.28 | 0.28 |





